December 23, 2021
The U.S. Food and Drug Administration approved Pfizer's new COVID-19 pill, dubbed Paxlovid, which will be available by prescription only to patients ages 12 and older. Photo by Volodymyr Hryshchenko on Unsplash
December 23, 2021
The U.S. Food and Drug Administration approved Pfizer's new COVID-19 pill, dubbed Paxlovid, which will be available by prescription only to patients ages 12 and older. Photo by Volodymyr Hryshchenko on Unsplash
Comments
Use the comment form below to begin a discussion about this content.
Sign in to comment
Or login with:
OpenID